1. Immune system adaptation during gender-affirming testosterone treatment.
- Author
-
Lakshmikanth T, Consiglio C, Sardh F, Forlin R, Wang J, Tan Z, Barcenilla H, Rodriguez L, Sugrue J, Noori P, Ivanchenko M, Piñero Páez L, Gonzalez L, Habimana Mugabo C, Johnsson A, Ryberg H, Hallgren Å, Pou C, Chen Y, Mikeš J, James A, Dahlqvist P, Wahlberg J, Hagelin A, Holmberg M, Degerblad M, Isaksson M, Duffy D, Kämpe O, Landegren N, and Brodin P
- Subjects
- Adult, Female, Humans, Male, Datasets as Topic, Dendritic Cells immunology, Dendritic Cells metabolism, Dendritic Cells drug effects, Immune System drug effects, Immune System metabolism, Interferon Type I immunology, Interferon Type I metabolism, Interferon-gamma immunology, Interferon-gamma metabolism, Interleukin-15 immunology, Interleukin-15 metabolism, Killer Cells, Natural immunology, Killer Cells, Natural drug effects, Monocytes immunology, Monocytes drug effects, Monocytes metabolism, NF-kappa B metabolism, Sex Characteristics, Tumor Necrosis Factor-alpha metabolism, Testosterone adverse effects, Testosterone immunology, Testosterone pharmacology, Testosterone therapeutic use, Transgender Persons
- Abstract
Infectious, inflammatory and autoimmune conditions present differently in males and females. SARS-CoV-2 infection in naive males is associated with increased risk of death, whereas females are at increased risk of long COVID
1 , similar to observations in other infections2 . Females respond more strongly to vaccines, and adverse reactions are more frequent3 , like most autoimmune diseases4 . Immunological sex differences stem from genetic, hormonal and behavioural factors5 but their relative importance is only partially understood6-8 . In individuals assigned female sex at birth and undergoing gender-affirming testosterone therapy (trans men), hormone concentrations change markedly but the immunological consequences are poorly understood. Here we performed longitudinal systems-level analyses in 23 trans men and found that testosterone modulates a cross-regulated axis between type-I interferon and tumour necrosis factor. This is mediated by functional attenuation of type-I interferon responses in both plasmacytoid dendritic cells and monocytes. Conversely, testosterone potentiates monocyte responses leading to increased tumour necrosis factor, interleukin-6 and interleukin-15 production and downstream activation of nuclear factor kappa B-regulated genes and potentiation of interferon-γ responses, primarily in natural killer cells. These findings in trans men are corroborated by sex-divergent responses in public datasets and illustrate the dynamic regulation of human immunity by sex hormones, with implications for the health of individuals undergoing hormone therapy and our understanding of sex-divergent immune responses in cisgender individuals., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF